Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine derivatives and iodine based molecules / APIs / Iodination reaction based bulk drugs. It also provides potassium iodide and iodate, sodium iodide, iodine, povidone, and iodoform products. In addition, the company offers integrated contract research and manufacturing services to pharmaceutical, agrochemical, nutraceutical, specialty chemicals and other chemical industries for iodine derivatives. The company also exports its products. It serves pharmaceutical and biotech, specialty and performance chemicals, dairy, food, and nutraceutical, animal care, agrochemical, paints, coatings, dyes, and textile, ink, paper and printing, rubber and nylon tyre, oil and gas, gold imitation and jewelry, medical, radiography, nuclear science, gemological, renewable energy, electrical, electronics, mechanical, aquarium, photography, tobacco and fireworks, as well as cosmetic, sanitation, personal care, and industrial care industries. The company was incorporated in 2003 and is based in Anand, India.
Metrics to compare | INFM | Peers Peers - average of corresponding metrics from companies closely matching INFM: MOREPENLAB, KOPRAN, 540694, ACCENTMIC, 524790 | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipINFMPeersSector |
---|---|---|---|---|
P/E Ratio | 37.5x | 26.1x | −0.6x | |
PEG Ratio | −1.95 | 0.22 | 0.00 | |
Price/Book | 5.6x | 3.2x | 2.6x | |
Price / LTM Sales | 2.3x | 2.2x | 3.3x | |
Upside (Analyst Target) | - | 13.7% | 40.1% | |
Fair Value Upside | Unlock | 6.5% | 5.3% | Unlock |